⚡Today

Chinese and French scientists win Shaw Prize for leukaemia cure

South China Morning Post 10 November 2026 3 min read

⏮ BeforeThe rare form of leukaemia was often deadly.
✅ NowIt is now widely curable, according to the researchers' work.

In short

  • The 2026 Shaw Prize in Life Science and Medicine went to Chinese and French winners.
  • Their research turned a rare form of leukaemia from deadly to widely curable.
  • The award was presented at a ceremony in Hong Kong attended by Chief Executive John Lee Ka-chiu.

Why it's good news

The winners describe their work as an East meets West collaboration across borders. The prize recognises research that changed a disease once usually fatal. The source does not give the number of patients affected or the exact treatment details.

Advertisement

From South China Morning Post

The Chinese and French winners of the 2026 Shaw Prize in Life Science and Medicine have highlighted the spirit of “borderless connections” and friendship behind their research – which turned a rare form of leukaemia from deadly to widely curable. At an awards ceremony at the Hong Kong Convention and Exhibition Centre on Tuesday attended by Chief Executive John Lee Ka-chiu, the life scientists celebrated their breakthrough as an “East meets West” success story and called for collaboration to...

Read the full story at South China Morning Post Opens the publisher's site in a new tab.

Ask this story

An AI model answers from the material behind this story only, with a link to the source. Your question is sent to our AI provider and isn't stored. See Privacy.

More like this

Advertisement
AdMobile anchor